BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Indian Pharma Stocks Plunge on Trump’s 100% Tariff Announcement
Indian Pharma Stocks Plunge on Trump’s 100% Tariff Announcement
19
3
BTCCSquare news:
Indian pharmaceutical stocks opened sharply lower, with the Nifty Pharma index dropping 1.82% to 21,576.85 points following US President Donald Trump's unexpected tariff announcement. The sector saw broad-based selling, with 19 of 20 stocks declining—Natco Pharma led losses at 3.51%, while only IPCA Labs eked out a 0.1% gain.
The 100% import tariff on branded drugs, effective October 2025, threatens India's $10 billion pharmaceutical exports to the US—its largest market. Analysts warn of potential spillover effects on complex generics, though exemptions exist for companies building US manufacturing facilities.
By:
